Evidence map›Paper›PMID 37375300›Full record

ArticleMolecules (Basel, Switzerland)2023

Analytical Quality by Design-Compliant Development of a Cyclodextrin-Modified Micellar ElectroKinetic Chromatography Method for the Determination of Trimecaine and Its Impurities.

Luca Marzullo, Roberto Gotti, Serena Orlandini, Patricie Slavíčková, Jakub Jireš, Michal Zapadlo, Michal Douša, Pavla Nekvapilová, Pavel Řezanka, Sandra Furlanetto

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.9field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 8 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Luca MarzulloDepartment of Chemistry "U. Schiff", University of Florence, 50019 Sesto Fiorentino, Italy.ORCID 0000-0002-6384-3035
Roberto GottiDepartment of Pharmacy and Biotechnology, University of Bologna, 40126 Bologna, Italy.ORCID 0000-0003-0622-2248
Serena OrlandiniDepartment of Chemistry "U. Schiff", University of Florence, 50019 Sesto Fiorentino, Italy.ORCID 0000-0002-6000-5079
Patricie SlavíčkováZentiva, k.s., 10237 Prague, Czech Republic.
Jakub JirešZentiva, k.s., 10237 Prague, Czech Republic.ORCID 0000-0002-3785-8153
Michal ZapadloZentiva, k.s., 10237 Prague, Czech Republic.
Michal DoušaZentiva, k.s., 10237 Prague, Czech Republic.ORCID 0000-0002-9188-6585
Pavla NekvapilováDepartment of Analytical Chemistry, Faculty of Chemical Engineering, UCT Prague, 16628 Prague, Czech Republic.
Pavel ŘezankaDepartment of Analytical Chemistry, Faculty of Chemical Engineering, UCT Prague, 16628 Prague, Czech Republic.ORCID 0000-0002-2997-9748
Sandra FurlanettoDepartment of Chemistry "U. Schiff", University of Florence, 50019 Sesto Fiorentino, Italy.
University of Chemistry and Technology, Prague · CZUniversity of Florence · ITUniversity of Bologna · IT

Funding

University of Chemistry and Technology Prague Grant No A2_FCHI_2022_005
6 · The paper itself

Abstract

In 2022, the International Council for Harmonisation released draft guidelines Q2(R2) and Q14, intending to specify the development and validation activities that should be carried out during the lifespan of an analytical technique addressed to assess the quality of medicinal products. In the present study, these recommendations were implemented in Capillary Electrophoresis method development for the quality control of a drug product containing trimecaine, by applying Analytical Quality by Design. According to the Analytical Target Profile, the procedure should be able to simultaneously quantify trimecaine and its four impurities, with specified analytical performances. The selected operative mode was Micellar ElectroKinetic Chromatography employing sodium dodecyl sulfate micelles supplemented with dimethyl-β-cyclodextrin, in a phosphate-borate buffer. The Knowledge Space was investigated through a screening matrix encompassing the composition of the background electrolyte and the instrumental settings. The Critical Method Attributes were identified as analysis time, efficiency, and critical resolution values. Response Surface Methodology and Monte Carlo Simulations allowed the definition of the Method Operable Design Region: 21-26 mM phosphate-borate buffer pH 9.50-9.77; 65.0 mM sodium dodecyl sulfate; 0.25-1.29%

Indexed as

Chromatography, Micellar Electrokinetic CapillaryCyclodextrinsBoratesMicellesReproducibility of ResultsSodium Dodecyl SulfateTrimecaineBoratesCyclodextrinsMicellesSodium Dodecyl SulfateTrimecainecapillary electrophoresisexperimental designimpuritiesmethod operable design regionquality by designtrimecaine

Identifiers

PMID37375300
PMCPMC10302722
OpenAlexW4380682375

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.